Engineers Gate Manager’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
Engineers Gate Manager's LKFT Position: Q3 2026 in Review
Engineers Gate Manager opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 11,761 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #1727 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in LKFT as recently as Q2 2025.
Engineers Gate Manager first reported a position in LKFT in Q1 2020 and has held it in 5 quarters since. The position peaked at $560K in Q2 2025. 95 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- Engineers Gate Manager held 11,761 shares of Lakefront Biotherapeutics American Depositary Shares worth $349K as of Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares was a new Engineers Gate Manager position in Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Engineers Gate Manager's portfolio in Q3 2026, its #1727 holding.
- Engineers Gate Manager first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and has held it in 5 quarters since.
- Engineers Gate Manager's Lakefront Biotherapeutics American Depositary Shares position peaked at $560K in Q2 2025.
- 95 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on Engineers Gate Manager's 13F filing for Q3 2026, filed 16 Nov 2026.